NCT07819786

Brief Summary

Breast cancer is one of the most common malignancies and represents an important public health problem. Modified radical mastectomy (MRM) is frequently associated with acute postoperative pain resulting from a combination of somatic and neuropathic mechanisms. Inadequately controlled postoperative pain may impair recovery, delay mobilization, increase opioid consumption, and negatively affect patient satisfaction and quality of life. Therefore, effective multimodal analgesia is an important component of perioperative care in patients undergoing breast surgery. Ultrasound-guided regional anesthesia techniques have gained increasing attention because they can provide effective postoperative analgesia while reducing opioid requirements and opioid-related adverse effects. The erector spinae plane block (ESPB) and rhomboid intercostal and subserratus plane (RISS) block are ultrasound-guided fascial plane techniques that may provide analgesia for thoracic and breast surgery. The aim of this randomized controlled study is to compare the postoperative analgesic efficacy of ultrasound-guided ESPB and RISS block in patients undergoing modified radical mastectomy and sentinel lymph node excision. The primary objective is to compare postoperative opioid consumption between the two techniques. Secondary outcomes include postoperative pain scores, analgesic requirements, and patient satisfaction. The hypothesis of the study is that ESPB and RISS block are comparable in terms of postoperative analgesic efficacy and that neither technique is superior to the other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
Last Updated

September 15, 2026

Status Verified

December 1, 2025

Enrollment Period

8 months

First QC Date

September 9, 2026

Last Update Submit

September 9, 2026

Conditions

Keywords

erector spinae blockRhomboid Intercostal Sub-serratus Plane Blockradical mastectomyPostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • 24-hour postoperative tramadol consumption

    Total tramadol consumption during the first 24 postoperative hours will be recorded from the patient-controlled analgesia (PCA) device. The total amount of tramadol administered through the PCA device will be compared between the ESPB and RISS groups.

    From the end of surgery to 24 hours postoperatively

Secondary Outcomes (4)

  • Postoperative static pain intensity assessed by the Numeric Rating Scale (NRS)

    Postoperative 0, 1, 2, 4, 6, 12, and 24 hours

  • Postoperative dynamic pain intensity assessed by the Numeric Rating Scale (NRS)

    Postoperative 0, 1, 2, 4, 6, 12, and 24 hours

  • Patient satisfaction with postoperative pain management assessed using a Likert scale

    24 hours after surgery

  • Incidence of opioid-related adverse effects

    From the end of surgery to 24 hours postoperatively

Study Arms (2)

ESPB(erector spinae plane block)

EXPERIMENTAL

Participants randomized to the ESPB group will receive an ultrasound-guided erector spinae plane block (ESPB) at the T5 vertebral level unilaterally.

Other: Erector Spinae Plane Block

RISSb(rhomboid intercostal subserratus plane block)

EXPERIMENTAL

Participants randomized to the RISS group will receive an ultrasound-guided rhomboid intercostal and subserratus plane (RISS) block unilaterally.

Other: Rhomboid Intercostal and Sub-Serratus block

Interventions

Participants randomized to the ESPB group will receive an ultrasound-guided erector spinae plane block (ESPB) at the T5 vertebral level bilaterally. The block will be performed in the operating room after completion of surgery and before emergence from general anesthesia. Under ultrasound guidance, the erector spinae muscle and transverse process will be identified, and 30 mL of 0.25% bupivacaine will be injected into the erector spinae plane. Participants will subsequently receive standardized multimodal postoperative analgesia according to the study protocol.

ESPB(erector spinae plane block)

Participants randomized to the RISS group will receive an ultrasound-guided rhomboid intercostal and subserratus plane (RISS) block bilaterally. The block will be performed in the operating room after completion of surgery and before emergence from general anesthesia. Under ultrasound guidance, 30 mL of 0.25% bupivacaine will be administered according to the RISS block technique. Participants will subsequently receive standardized multimodal postoperative analgesia according to the study protocol.

RISSb(rhomboid intercostal subserratus plane block)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 80 years.
  • American Society of Anesthesiologists (ASA) physical status classification I-III.
  • Scheduled for elective modified radical mastectomy.
  • Willingness to participate in the study and ability to provide written informed consent.

You may not qualify if:

  • Participants will be excluded if they meet any of the following criteria:
  • Refusal to participate in the study or inability to provide informed consent.
  • Known or suspected allergy to local anesthetic agents.
  • Coagulopathy or a contraindication to regional anesthesia.
  • Requirement for uninterrupted anticoagulant therapy.
  • Infection at the site of block injection.
  • Any other condition considered by the investigators to make participation in the study inappropriate or unsafe.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa City Hospital

Bursa, nilüfer, 16010, Turkey (Türkiye)

Location

Related Publications (1)

  • 1.Ç. Erhan, "Meme Kanseri Tedavileri ve Tiroid Fonksiyonları Üzerine Etkileri," 2026, pp. 487-493. doi: 10.37609/akya.3852.c2823. 2.M. Liu, C. Wang, F. Xie, P. Yuan, and S. Wang, "Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021," Chinese Medical Journal , vol. 134, no. 9, pp. 1009-1013, Apr. 2021, doi: 10.1097/cm9.0000000000001498. 3.C. Kubulus et al., "Does the quality of pain relief after major surgery influence the risk of postoperative complications? A prospective observational study," PLoS ONE, vol. 20, no. 9, Sep. 2025, doi: 10.1371/journal.pone.0332866. 4.A. Günay and A. Karahan, "Mastektomi ile Eş Zamanlı Meme Rekonstrüksiyonu Uygulanan Hastalarda Dijital Teknoloji Destekli Eğitim ve İzlemin Anksiyete, Ağrı, Uyku ve Yaşam Kalitesi Üzerine Etkisi: Randomize Kontrollü Çalışma Protokolü," Aug. 2024, Accessed: Jun. 2026. [Online]. Available: https://dergipark.org.tr/tr/pub/busbid/issue/89033/1541211 5.M. Şimşek, "Regional Anestezi İlkeleri ve Uygulamaları," 2025, pp. 39-54. doi: 10.37609/akya.3854.c1286. 6.P. Kumar, S. Yadav, and R. Agarwal, "Enhanced Recovery After Surgery (ERAS): Role of the Anesthesiologist," International Journal of Current Pharmaceutical Review and Research, vol. 18, no. 2, Feb. 2026, doi: 10.25258/ijcpr.18.2.132. 7.R. Abid et al., "Postoperative Pain Control Using Regional Nerve Blocks in Breast Cancer Surgery Mastectomy," Journal of Health Wellness and Community Research, Jun. 2025, doi: 10.61919/hdnm5b63. 8.S. Du, Q. Xie, T. Liang, and Y. Feng, "The Application of Erector Spinae Plane Block in Chronic Pain Management: From Anatomical Mechanisms to Clinical Innovations," Journal of Pain Research, pp. 7139-7148, Dec. 2025, doi: 10.2147/jpr.s548853. 9.A. Clairoux et al., "Erector spinae plane block did not improve postoperative pain-related outcomes and recovery after video-assisted thoracoscopic surgery : a randomised cont

    BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

September 9, 2026

First Posted

September 15, 2026

Study Start

January 1, 2026

Primary Completion

September 1, 2026

Study Completion

September 1, 2026

Last Updated

September 15, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared

Locations